Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently

Molecular and Cellular Biology

Volumn 22, Issue 2, 2002, Pages 587-598

  Young, M R ^a   Nair, R ^a   Bucheimer, N ^a   Tulsian, P ^a   Brown, N ^a   Chapp, C ^a   Hsu, T ^a   Colburn, N H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TUMOR PROMOTER;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPIDERMIS CELL; EXPRESSION VECTOR; GENETIC TRANSCRIPTION; MALIGNANT TRANSFORMATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CARCINOGENS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GENES, FOS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; VARIATION (GENETICS);

ANIMALIA; MUS MUSCULUS; VECTORS;

EID: 0036134934     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.2.587-598.2002     Document Type: Article

References (71)

1. Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions
2. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
3. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cipl and a subset of AP-1 proteins in CCL39 cells
4. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation
5. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron
6. 12-O-Tetradecanoyl-phorbol-13-acetate-induced levels of AP-1 proteins: A 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells
7. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells
8. Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding and JunD expression and form different AP-1-DNA complexes than promotion sensitive cells
9. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
10. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control
11. Suppression of oncogene-induced transformation by a deletion mutant of c-jun
12. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase
13. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity
14. Nuclear localization and regulation of erk- and rsk-encoded protein kinases
15. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
16. MAP kinase pathways
17. Regulation of the MAP kinase cascade
18. fra-1: A serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen
19. Tumour promoter induces anchorage independence irreversibly
20. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells
21. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: Mitogen-resistant variants are sensitive to promotion
22. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation
23. Fos and Jun: The AP-1 connection
24. MAPKs: New JNK expands the group
25. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK
26. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice
27. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells
28. A dominant negative mutant of Jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes
29. Fra-1 replaces c-fos-dependent functions in mice
30. Cloning and characterisation of the mouse fra-2 gene
31. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum
32. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains
33. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter
34. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity
35. Inducible binding of a factor to the c-fos regulatory region
36. Transcriptional regulation by extracellular signals: Mechanisms and specificity
37. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells
38. Sequential protein kinase reactions controlling cell growth and differentiation
39. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus
40. AP-1 function and regulation
41. TFII-I enhances activation of the c-fos promoter through interactions with upstream elements
42. Differential functional significance of AP-1 binding sites in the promoter of the gene encoding mouse tissue inhibitor of metalloproteinases-3
43. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells
44. The stress-activated protein kinase subfamily of c-Jun kinases
45. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts
46. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element
47. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes
48. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response
49. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
50. Ras target proteins in eukaryotic cells
51. Fos11 is a transcriptional target of c-Fos during osteoclast differentiation
52. Transformation by ras modifies AP1 composition and activity
53. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK
54. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
55. elk-1 proteins interact with MAP kinases
56. Fos-associated protein p39 is the product of the jun proto-oncogene
57. Common DNA binding site for Fos protein complexes and transcription factor AP-1
58. Regulation and properties of extracellular signal-regulated protein kinases 1, 2, and 3
59. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation
60. c-fos is required for malignant progression of skin tumors
61. Transcription factor phosphorylation by pp90(rsk2): Identification of Fos kinase and NGFI-B kinase I as pp90(rsk2)
62. Activated MEK stimulates expression of AP-I 1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis
63. Regulation of transcription by MAP kinase cascades
64. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMG1-C gene product
65. AP-1 articles
66. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation
67. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
68. Integration of MAP kinase signal transduction pathways at the serum response element
69. Transformation by Fos proteins requires a C-terminal transactivation domain
70. Antitumor promotion by phenolic antioxidants: Inhibition of AP-1 activity through induction of Fra expression
71. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion